Brief: Kinnate Biopharma Reports Full Year 2021 Financial Results And Provides Operational Updates
28/03/2022 21:14
March 28 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC. REPORTS FULL YEAR 2021 FINANCIAL
RESULTS
AND PROVIDES OPERATIONAL UPDATES
* KINNATE BIOPHARMA - AS OF DECEMBER 31, 2021, TOTAL OF CASH
&
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS $324.9 MILLION,
EXCLUSIVE OF JOINT VENTURE'S CASH
Source text for Eikon: ID:nGNX1yCXNd
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview